Europe Allergy Treatment Market Growth and Forecast by 2028
Europe Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies) and Treatment (Anti-Allergy Drugs and Immunotherapy)
- Status : Published
- Report Code : TIPRE00022082
- Category : Life Sciences
- No. of Pages : 155
- Available Report Formats :
- Last update date : May 05, 2021
2020 Market Size
US$ 6,036.60 Mn
Base year value
2028 Forecast
US$ 10,424.97 Mn
Projected by 2028
CAGR 2021-2028
7.1 %
Growth rate
Addressable Market
US$ 66,571.01 Mn
(2021-2028)
The Europe allergy treatment market is expected to reach US$ 10,424.97 million by 2028 from US$ 6,036.60 million in 2020, it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.
The market growth is attributed to key driving factors such as increase in adoption of immunotherapy in allergy treatment and developments in food allergy treatments. However, the lack of awareness about allergy treatments restrains the market growth.The allergies are hypersensitive responses from human immune system to the substance that are foreign to the body. While allergies can disturb the normal functioning of organs, severe allergies can be life threatening; for example, asthma leads to poor lung functioning. Although the most effective method of gaining protection against allergies is to avoid being exposed to the known allergens, medications such as steroids and antihistamines are available for treating them. According to a European survey in 2019, in Europe, the prevalence of allergic rhinitis ranges from 17 to 29%, whereas the prevalence of asthma varies from 1.3 to 11% among children and adults. Immunotherapy has shown positive and long-term benefits in allergic patients. In addition, it is suitable for self-administration and medicine usage in homecare settings. Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for both chronic and recurrent allergies. Also, developments in the pharmaceuticals industry have enabled companies to offer treatment for varied allergy reactions. Such developments in the food allergy treatment options and their effectiveness boost the growth of the Europe allergy treatment market.
The rapid growth of COVID-19 cases in Europe has had a major impact on the European economy. Amid COVID-19 outbreak pandemic, it is discovered that a significant number of people across the world are suffering from chronic respiratory diseases such as respiratory allergies, allergic rhinitis, and sinusitis. EAACI, in collaboration with ARIA, in Europe has provided recommendations on operational plans and practical procedures for ensuring optimal standards in the daily clinical care of patients affected by allergic diseases. Therefore, the growing demand for allergy treatments in Europe boosts the growth of the allergy treatment market in the region.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
EUROPE ALLERGY TREATMENT MARKET SEGMENTATION
By Allergy Type:
- Eye Allergy
- Rhinitis
- Asthma
- Skin Allergy
- Food Allergies
- Other Allergies
By Treatment:
- Anti-Allergy Drugs
- Antihistamines
- Corticosteroids
- Decongestants
- Other Drugs
- Immunotherapy
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-Lingual Immunotherapy (SLIT)
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- LETI Pharma
- Dermapharm Holding Se
- Johnson and Johnson Services, Inc.
- Sanofi
- AbbVie's Inc.
- Pfizer
- ALK-Abelló A/S
- Allergy Therapeutics
- Stallergenes Greer
- GlaxoSmithKline PLC
Europe Allergy Treatment Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 6,036.60 Million |
| Market Size by 2028 | US$ 10,424.97 Million |
| CAGR (2021 - 2028) | 7.1% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Allergy Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners provided valuable market intelligence that supported our global go-to-market strategy. Their team was professional, responsive, and attentive to our feedback, providing thoughtful analysis and helpful methodological clarifications throughout the project.
Junmo Kim Chief Financial Officer (CFO), Enertech Co., Ltd.
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for